Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Dara Aisner

Concepts (388)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
59
2022
2199
5.270
Why?
Carcinoma, Non-Small-Cell Lung
39
2022
993
3.670
Why?
Genetic Testing
8
2019
365
2.580
Why?
Pathology, Molecular
7
2019
27
2.440
Why?
ErbB Receptors
17
2019
553
2.250
Why?
Oncogene Proteins, Fusion
13
2019
203
2.230
Why?
Mutation
34
2022
3403
1.910
Why?
Molecular Diagnostic Techniques
3
2020
96
1.880
Why?
Protein Kinase Inhibitors
22
2021
857
1.760
Why?
High-Throughput Nucleotide Sequencing
10
2020
419
1.690
Why?
Proto-Oncogene Proteins
17
2018
715
1.540
Why?
Protein-Tyrosine Kinases
12
2018
448
1.520
Why?
Proto-Oncogene Proteins B-raf
12
2018
197
1.470
Why?
Biomarkers, Tumor
16
2021
1060
1.310
Why?
Neoplasms
10
2019
2079
1.310
Why?
DNA, Neoplasm
3
2019
160
1.290
Why?
Proto-Oncogene Proteins p21(ras)
11
2020
238
1.240
Why?
Receptor Protein-Tyrosine Kinases
10
2019
277
1.220
Why?
Antineoplastic Agents
15
2019
2037
1.210
Why?
Proto-Oncogene Proteins c-met
5
2019
72
1.110
Why?
Drug Resistance, Neoplasm
12
2022
681
1.080
Why?
Gene Rearrangement
13
2019
170
0.970
Why?
Adenocarcinoma
9
2018
814
0.960
Why?
Brain Neoplasms
10
2018
983
0.940
Why?
Ganglioglioma
4
2014
34
0.890
Why?
DNA Mutational Analysis
11
2020
410
0.840
Why?
Precision Medicine
4
2018
296
0.830
Why?
Molecular Targeted Therapy
10
2018
380
0.820
Why?
Insurance, Health, Reimbursement
1
2020
97
0.760
Why?
Pyrazoles
10
2018
400
0.760
Why?
Neoplasms, Muscle Tissue
1
2019
6
0.760
Why?
Receptors, Nerve Growth Factor
1
2019
18
0.760
Why?
Astrocytoma
3
2015
111
0.740
Why?
Insurance Coverage
1
2020
219
0.710
Why?
Prognosis
12
2019
3550
0.680
Why?
Humans
105
2022
115146
0.670
Why?
Neoplasm Metastasis
9
2022
611
0.670
Why?
In Situ Hybridization, Fluorescence
13
2019
340
0.670
Why?
Computational Biology
3
2019
481
0.660
Why?
Laboratory Proficiency Testing
1
2016
7
0.620
Why?
RNA
5
2019
779
0.610
Why?
Adenocarcinoma, Mucinous
1
2015
54
0.560
Why?
Immunohistochemistry
9
2019
1784
0.560
Why?
Small Cell Lung Carcinoma
1
2016
82
0.540
Why?
Tumor Suppressor Protein p53
2
2017
466
0.540
Why?
ras Proteins
5
2015
146
0.520
Why?
Neoplasm Recurrence, Local
3
2022
806
0.510
Why?
Smoking
3
2018
1596
0.500
Why?
Pyridines
8
2016
499
0.490
Why?
AMP-Activated Protein Kinases
1
2014
156
0.480
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2019
1394
0.460
Why?
Colorectal Neoplasms
2
2020
595
0.450
Why?
Neoplasm Staging
11
2018
1219
0.450
Why?
Aged, 80 and over
15
2020
6845
0.430
Why?
Telomerase
7
2002
223
0.430
Why?
S100 Proteins
2
2014
41
0.430
Why?
TOR Serine-Threonine Kinases
1
2014
358
0.430
Why?
Male
48
2022
60969
0.400
Why?
Aged
27
2020
20309
0.390
Why?
Early Detection of Cancer
2
2019
307
0.390
Why?
Female
46
2022
63296
0.390
Why?
Sulfones
3
2015
104
0.380
Why?
Glycine
3
2015
157
0.370
Why?
Curriculum
1
2016
848
0.370
Why?
Genomics
3
2019
518
0.370
Why?
Pyrimidines
3
2018
408
0.360
Why?
Middle Aged
34
2020
28958
0.350
Why?
Adrenal Gland Neoplasms
2
2022
74
0.350
Why?
Head and Neck Neoplasms
3
2019
420
0.340
Why?
Neoplasms, Multiple Primary
2
2022
52
0.330
Why?
Class I Phosphatidylinositol 3-Kinases
4
2022
79
0.320
Why?
Oncogene Fusion
2
2019
10
0.320
Why?
Gene Dosage
2
2018
134
0.320
Why?
Exons
5
2019
305
0.320
Why?
Receptor, Fibroblast Growth Factor, Type 1
2
2018
58
0.310
Why?
Antineoplastic Agents, Immunological
2
2018
155
0.310
Why?
Melanoma
2
2020
718
0.310
Why?
Treatment Outcome
11
2019
9218
0.310
Why?
Oncogenes
3
2016
108
0.290
Why?
Genetic Predisposition to Disease
6
2019
2197
0.290
Why?
Sodium-Phosphate Cotransporter Proteins, Type IIb
3
2015
13
0.290
Why?
Immunotherapy
5
2022
459
0.290
Why?
Adult
29
2022
32202
0.280
Why?
Epithelioid Cells
2
2015
8
0.280
Why?
Receptor, ErbB-2
4
2022
328
0.270
Why?
Carcinoma, Squamous Cell
3
2019
558
0.250
Why?
Sensitivity and Specificity
5
2019
1922
0.250
Why?
Cell Line, Tumor
11
2018
2891
0.240
Why?
Survival Analysis
4
2021
1410
0.240
Why?
Biopsy, Fine-Needle
2
2012
64
0.230
Why?
Gene Fusion
2
2018
22
0.220
Why?
Glioblastoma
2
2015
247
0.220
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2022
30
0.220
Why?
Patient Selection
4
2018
707
0.220
Why?
Young Adult
12
2019
11032
0.220
Why?
Pheochromocytoma
1
2022
51
0.210
Why?
Meningioma
1
2022
69
0.210
Why?
Cell Proliferation
7
2017
2373
0.210
Why?
Biopsy
4
2018
1050
0.210
Why?
Trastuzumab
1
2021
104
0.210
Why?
Carbazoles
1
2021
95
0.210
Why?
Combined Modality Therapy
4
2018
1217
0.210
Why?
Laboratories, Hospital
1
2020
15
0.200
Why?
United States
9
2020
12598
0.200
Why?
GTP Phosphohydrolases
1
2020
65
0.200
Why?
Government Regulation
1
2020
48
0.200
Why?
Pathology, Clinical
2
2017
36
0.200
Why?
Piperidines
1
2021
182
0.190
Why?
Costs and Cost Analysis
1
2020
206
0.190
Why?
Stakeholder Participation
1
2020
67
0.190
Why?
Chromosome Aberrations
2
2019
146
0.190
Why?
Endoscopic Ultrasound-Guided Fine Needle Aspiration
2
2017
55
0.190
Why?
Genes, erbB-2
2
2015
28
0.190
Why?
Cell Transformation, Neoplastic
3
2018
339
0.190
Why?
Multiplex Polymerase Chain Reaction
1
2019
40
0.180
Why?
Smad4 Protein
1
2019
37
0.180
Why?
Genetic Heterogeneity
1
2019
57
0.180
Why?
Acrylamides
2
2017
43
0.180
Why?
Breast Neoplasms, Male
1
2018
31
0.180
Why?
Multigene Family
1
2019
202
0.180
Why?
Pyridazines
1
2018
57
0.180
Why?
Pathologists
1
2018
12
0.180
Why?
Genetic Markers
1
2019
350
0.170
Why?
Thromboembolism
1
2018
101
0.170
Why?
Cell-Free Nucleic Acids
1
2018
23
0.170
Why?
Database Management Systems
1
2018
49
0.170
Why?
Skin Neoplasms
2
2020
763
0.170
Why?
Gene Frequency
1
2019
431
0.170
Why?
Piperazines
2
2018
328
0.170
Why?
Programmed Cell Death 1 Receptor
2
2018
178
0.170
Why?
Cell Cycle Proteins
4
2015
573
0.170
Why?
Genetic Association Studies
1
2019
345
0.170
Why?
Quinazolines
3
2014
245
0.170
Why?
Intraoperative Care
1
2017
49
0.170
Why?
B7-H1 Antigen
1
2018
135
0.160
Why?
Smokers
1
2018
146
0.160
Why?
Indoles
2
2017
348
0.160
Why?
Radiotherapy, Intensity-Modulated
1
2018
135
0.160
Why?
Medical Informatics
1
2018
100
0.160
Why?
Gene Deletion
1
2019
382
0.160
Why?
Imidazoles
1
2018
264
0.160
Why?
Chloroquine
1
2017
65
0.160
Why?
Coculture Techniques
1
2017
204
0.150
Why?
Small Molecule Libraries
1
2017
83
0.150
Why?
Clinical Decision-Making
1
2019
281
0.150
Why?
Neoadjuvant Therapy
1
2018
290
0.150
Why?
Pleural Effusion, Malignant
1
2016
17
0.150
Why?
Liver Neoplasms
3
2015
463
0.150
Why?
Carcinogenesis
1
2017
161
0.150
Why?
Pleural Neoplasms
1
2016
21
0.150
Why?
Triple Negative Breast Neoplasms
1
2018
149
0.150
Why?
Sulfonamides
2
2017
455
0.150
Why?
Peritoneal Neoplasms
1
2016
53
0.150
Why?
Proto-Oncogene Proteins c-kit
1
2016
65
0.150
Why?
Immunity, Humoral
1
2016
103
0.150
Why?
Codon
1
2016
90
0.150
Why?
Neoplastic Cells, Circulating
1
2016
63
0.150
Why?
RNA, Messenger
4
2018
2835
0.140
Why?
Positron Emission Tomography Computed Tomography
1
2016
74
0.140
Why?
Medicare
1
2020
668
0.140
Why?
Laboratories
1
2016
100
0.140
Why?
Oncogene Proteins
1
2015
63
0.140
Why?
Hamartoma
1
2015
18
0.140
Why?
Fatal Outcome
1
2016
314
0.140
Why?
Amino Acid Substitution
1
2016
287
0.140
Why?
Clinical Laboratory Techniques
1
2016
99
0.140
Why?
Protein Kinases
1
2017
337
0.140
Why?
Signal Transduction
5
2017
4905
0.140
Why?
Sequence Analysis, RNA
1
2017
405
0.140
Why?
Pharmacogenetics
1
2016
150
0.140
Why?
Spinal Cord Neoplasms
1
2014
35
0.140
Why?
DNA Copy Number Variations
4
2018
143
0.140
Why?
Meningeal Carcinomatosis
1
2014
8
0.140
Why?
Immunity, Cellular
1
2016
303
0.140
Why?
Genetic Variation
1
2019
825
0.130
Why?
Paresis
1
2014
20
0.130
Why?
Deoxycytidine
1
2015
146
0.130
Why?
Practice Guidelines as Topic
2
2019
1543
0.130
Why?
Retrospective Studies
9
2019
11727
0.130
Why?
Lung Transplantation
1
2016
311
0.130
Why?
Multimodal Imaging
1
2015
102
0.130
Why?
Alternative Splicing
3
2017
208
0.130
Why?
Speech Disorders
1
2014
42
0.130
Why?
Wnt Signaling Pathway
1
2015
137
0.130
Why?
Sarcoma
1
2015
132
0.130
Why?
Health Care Surveys
1
2016
586
0.130
Why?
Receptor, trkA
1
2013
25
0.130
Why?
Polymerase Chain Reaction
2
2014
1048
0.130
Why?
Intracranial Hemorrhages
1
2014
66
0.130
Why?
Membrane Proteins
1
2020
1092
0.130
Why?
Mitogen-Activated Protein Kinases
1
2015
369
0.130
Why?
Microscopy, Electron
1
2014
446
0.120
Why?
Tumor Cells, Cultured
5
2019
1002
0.120
Why?
Serine Endopeptidases
1
2013
102
0.120
Why?
Brain Stem Neoplasms
1
2013
79
0.120
Why?
Graft Rejection
1
2016
591
0.120
Why?
Bone Neoplasms
1
2015
198
0.120
Why?
Autophagy
1
2017
317
0.120
Why?
Gene Expression Regulation, Neoplastic
1
2019
1200
0.120
Why?
Headache
1
2014
154
0.120
Why?
Positron-Emission Tomography
1
2015
306
0.120
Why?
Dose-Response Relationship, Drug
5
2021
2187
0.120
Why?
Tissue Fixation
1
2012
30
0.120
Why?
Societies, Medical
4
2018
764
0.120
Why?
Gene Amplification
3
2019
106
0.120
Why?
Microtubule-Associated Proteins
1
2013
195
0.110
Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2017
1090
0.110
Why?
Predictive Value of Tests
2
2015
1997
0.110
Why?
Recombinant Fusion Proteins
2
2013
697
0.110
Why?
Disease Progression
5
2018
2494
0.110
Why?
Mutation Rate
1
2011
22
0.110
Why?
Lung
4
2015
3580
0.110
Why?
Translocation, Genetic
1
2012
118
0.110
Why?
Algorithms
1
2019
1519
0.110
Why?
Education, Medical, Graduate
1
2016
397
0.110
Why?
Tomography, X-Ray Computed
3
2018
2397
0.110
Why?
Rhabdoid Tumor
1
2011
76
0.110
Why?
Teratoma
1
2011
91
0.100
Why?
Specimen Handling
1
2012
172
0.100
Why?
Interdisciplinary Communication
1
2012
205
0.100
Why?
Terminology as Topic
1
2012
202
0.100
Why?
Epithelial Cells
1
2017
1016
0.100
Why?
Genome, Human
1
2012
303
0.100
Why?
Breast Neoplasms
1
2022
1934
0.100
Why?
DNA-Binding Proteins
6
2011
1426
0.100
Why?
Xenograft Model Antitumor Assays
3
2019
779
0.100
Why?
Erlotinib Hydrochloride
3
2014
68
0.090
Why?
Immunoenzyme Techniques
3
2015
224
0.090
Why?
Telomere
3
2000
203
0.090
Why?
Catheter Ablation
1
2012
330
0.090
Why?
Phosphorylation
1
2014
1734
0.090
Why?
Survival Rate
4
2019
1862
0.090
Why?
Disease-Free Survival
3
2016
686
0.090
Why?
Medical Oncology
2
2022
209
0.090
Why?
Leukemia-Lymphoma, Adult T-Cell
1
2008
15
0.090
Why?
Phosphatidylinositol 3-Kinases
3
2015
358
0.090
Why?
Proto-Oncogene Proteins c-ret
2
2018
26
0.090
Why?
Pancreatic Neoplasms
1
2015
728
0.090
Why?
Heart Neoplasms
1
2008
44
0.090
Why?
Diagnosis, Differential
1
2012
1419
0.090
Why?
Maximum Tolerated Dose
2
2021
189
0.080
Why?
Adolescent
6
2019
18712
0.080
Why?
Follow-Up Studies
4
2021
4959
0.080
Why?
DNA
1
2014
1357
0.080
Why?
Workflow
2
2017
112
0.080
Why?
Reproducibility of Results
3
2019
2940
0.080
Why?
Prospective Studies
1
2017
6324
0.080
Why?
Internship and Residency
1
2016
991
0.070
Why?
Eye Neoplasms
1
2005
14
0.070
Why?
Mental Disorders
1
2014
954
0.070
Why?
Immunophenotyping
1
2005
297
0.070
Why?
Administration, Oral
2
2018
798
0.060
Why?
Genes, ras
2
2015
99
0.060
Why?
Antigens, Differentiation, B-Lymphocyte
2
2013
44
0.060
Why?
Real-Time Polymerase Chain Reaction
2
2015
348
0.060
Why?
Magnetic Resonance Imaging
1
2014
3157
0.060
Why?
Blotting, Western
4
2015
1294
0.060
Why?
Cell Cycle
2
2012
590
0.060
Why?
Cell Survival
2
2017
1139
0.060
Why?
Active Transport, Cell Nucleus
1
2002
129
0.060
Why?
Clinical Trials as Topic
2
2017
1005
0.050
Why?
Histocompatibility Antigens Class II
2
2013
370
0.050
Why?
Gene Expression Regulation, Enzymologic
1
2002
318
0.050
Why?
Gene Expression Profiling
2
2017
1582
0.050
Why?
Models, Molecular
2
2018
1546
0.050
Why?
Standard of Care
1
2020
87
0.050
Why?
Protein Processing, Post-Translational
1
2002
425
0.050
Why?
Base Sequence
3
2017
2280
0.050
Why?
Catalytic Domain
4
2000
199
0.050
Why?
HSP90 Heat-Shock Proteins
1
1999
52
0.050
Why?
Cell Nucleus
1
2002
611
0.040
Why?
Sequence Deletion
2
2014
192
0.040
Why?
Cohort Studies
2
2019
5026
0.040
Why?
Aurora Kinase A
1
2018
58
0.040
Why?
Radiotherapy, Image-Guided
1
2018
36
0.040
Why?
Proto-Oncogenes
1
2018
31
0.040
Why?
Phthalazines
1
2018
45
0.040
Why?
Child
5
2015
17937
0.040
Why?
Nausea
1
2018
116
0.040
Why?
Time Factors
3
2020
7041
0.040
Why?
Cetuximab
1
2018
97
0.040
Why?
RNA, Untranslated
1
1999
123
0.040
Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2017
23
0.040
Why?
Breast
1
2018
148
0.040
Why?
Cell Line
4
2012
2930
0.040
Why?
Diarrhea
1
2018
178
0.040
Why?
A549 Cells
1
2017
55
0.040
Why?
Quality Control
1
2017
166
0.040
Why?
Aniline Compounds
1
2017
62
0.040
Why?
Pathology, Surgical
1
2016
10
0.040
Why?
Structure-Activity Relationship
1
2018
553
0.040
Why?
Fatigue
1
2018
303
0.040
Why?
Centrosome
1
2016
59
0.040
Why?
Molecular Sequence Data
3
2013
3014
0.040
Why?
Carcinoma
2
2012
207
0.040
Why?
Drug Synergism
1
2017
359
0.040
Why?
Dual Specificity Phosphatase 6
1
2015
7
0.040
Why?
Consensus
1
2018
461
0.040
Why?
Guidelines as Topic
1
2018
291
0.040
Why?
Child, Preschool
3
2015
9680
0.040
Why?
Genes, erbB-1
1
2015
20
0.040
Why?
Lamin Type A
1
2015
39
0.040
Why?
Mitogen-Activated Protein Kinase Kinases
1
2015
126
0.040
Why?
Cell Line, Transformed
3
2000
166
0.040
Why?
Mice, Nude
1
2017
696
0.040
Why?
MAP Kinase Kinase 1
1
2015
74
0.030
Why?
Antimetabolites, Antineoplastic
1
2015
86
0.030
Why?
Transcription, Genetic
1
2002
1463
0.030
Why?
Respiratory Mucosa
1
2017
236
0.030
Why?
HEK293 Cells
1
2017
649
0.030
Why?
Multivariate Analysis
1
2018
1607
0.030
Why?
Sequence Analysis, DNA
1
2017
735
0.030
Why?
Antibodies, Monoclonal, Humanized
1
2018
654
0.030
Why?
Recurrence
1
2017
990
0.030
Why?
Fluorodeoxyglucose F18
1
2015
132
0.030
Why?
Intercellular Signaling Peptides and Proteins
1
2015
372
0.030
Why?
Microdissection
1
2013
14
0.030
Why?
beta Catenin
1
2015
226
0.030
Why?
Epidermal Growth Factor
1
2013
164
0.030
Why?
Radiopharmaceuticals
1
2015
200
0.030
Why?
Animals
5
2019
34755
0.030
Why?
Syndecan-4
1
2012
9
0.030
Why?
Drug Administration Schedule
1
2015
809
0.030
Why?
Randomized Controlled Trials as Topic
1
2018
1166
0.030
Why?
Transcriptome
1
2018
685
0.030
Why?
Papillomaviridae
1
2013
126
0.030
Why?
Proto-Oncogene Proteins c-akt
1
2015
458
0.030
Why?
Disease Management
1
2017
605
0.030
Why?
Bone and Bones
1
2015
258
0.030
Why?
Cooperative Behavior
1
2015
413
0.030
Why?
SMARCB1 Protein
1
2011
18
0.030
Why?
Incidence
1
2018
2456
0.030
Why?
Hyperglycemia
1
2015
336
0.030
Why?
Mice
2
2019
15478
0.030
Why?
Infant
2
2015
8124
0.030
Why?
Chromosomal Proteins, Non-Histone
1
2011
106
0.030
Why?
Lymphatic Metastasis
1
2012
313
0.030
Why?
Green Fluorescent Proteins
1
2012
417
0.030
Why?
Adaptor Proteins, Signal Transducing
1
2013
387
0.030
Why?
Papillomavirus Infections
1
2013
243
0.030
Why?
Bronchoscopy
1
2012
243
0.020
Why?
Polymorphism, Single Nucleotide
1
2017
1752
0.020
Why?
Reticulocytes
2
1999
17
0.020
Why?
Retroviridae
2
2000
95
0.020
Why?
Enzyme Inhibitors
1
2014
929
0.020
Why?
Hypertension
1
2018
1194
0.020
Why?
Cognition Disorders
1
2014
583
0.020
Why?
Protein Structure, Tertiary
1
2012
882
0.020
Why?
Sex Factors
1
2015
1977
0.020
Why?
Leukemic Infiltration
1
2008
5
0.020
Why?
Genetic Vectors
2
2000
321
0.020
Why?
Human T-lymphotropic virus 1
1
2008
20
0.020
Why?
Cells, Cultured
1
2017
4291
0.020
Why?
Longitudinal Studies
1
2015
2676
0.020
Why?
Rabbits
2
1999
795
0.020
Why?
DNA Primers
2
1999
579
0.020
Why?
National Institutes of Health (U.S.)
1
2008
110
0.020
Why?
T-Lymphocytes
1
2016
1807
0.020
Why?
Phenotype
1
2015
2861
0.020
Why?
In Vitro Techniques
2
1999
1231
0.020
Why?
Biomarkers
1
2017
3508
0.020
Why?
Fibroblasts
2
2000
869
0.020
Why?
Apoptosis
1
2015
2616
0.020
Why?
Transcription Factors
1
2011
1623
0.020
Why?
Infant, Newborn
1
2013
5076
0.020
Why?
Peptide Chain Termination, Translational
1
2000
4
0.010
Why?
Fetal Proteins
1
2000
17
0.010
Why?
Genes, Dominant
1
2000
97
0.010
Why?
Chromosomes, Human
1
2000
45
0.010
Why?
Fibrosarcoma
1
2000
21
0.010
Why?
DNA, Complementary
1
2000
288
0.010
Why?
RNA-Directed DNA Polymerase
1
1999
34
0.010
Why?
Protein Subunits
1
2000
231
0.010
Why?
Quinones
1
1999
14
0.010
Why?
Lactams, Macrocyclic
1
1999
49
0.010
Why?
Benzoquinones
1
1999
46
0.010
Why?
Cyclosporine
1
1999
180
0.010
Why?
Carcinoma, Renal Cell
1
2000
175
0.010
Why?
Transfection
1
2000
964
0.010
Why?
Molecular Chaperones
1
1999
175
0.010
Why?
Half-Life
1
1997
172
0.010
Why?
RNA, Long Noncoding
1
1999
149
0.010
Why?
Neoplasm Proteins
1
2000
436
0.010
Why?
Adenosine Triphosphate
1
1999
463
0.010
Why?
Recombinant Proteins
1
1999
1422
0.010
Why?
Skin
1
2000
680
0.010
Why?
Flow Cytometry
1
1997
1167
0.010
Why?
Prostatic Neoplasms
1
2000
957
0.010
Why?
Aisner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2023 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)